跳到正文
原文
NEJM· Ahmad Masri Martin S. Maron Ankit Bhatia Maria Luisa Peña-Peña Mark V. Sherrid Estevao Lanna Figueiredo Michael Arad Roberto Barriales-Villa Lubna Choudhury Brian L. Claggett Caroline J. Coats Edileide de Barros Correia Juan Pablo Costabel Perry M. Elliott Jorge E. Silva Enciso Pablo Garcia-Pavia Junbo Ge Sheila M. Hegde Gregory D. Lewis Renato D. Lopes Matthew W. Martinez Mathew S. Maurer Zi Michael Miao Michelle Michels Sumeet S. Mitter Jesus E. Pino Moreno Iacopo Olivotto Anjali T. Owens Steen H. Poulsen Florian Rader Ethan J. Rowin P. Christian Schulze Robert Sepp Nikhil Sikand Scott D. Solomon John A. Spertus Charles Teale Xiaoyan Zhao Punag H. Divanji Stephen B. Heitner Daniel L. Jacoby Stuart Kupfer Fady I. Malik Joel Salazar-Mendiguchía Amy Wohltman Shu Zhuo and Carolyn Y. Hothe ACACIA-HCM Investigators*·· 2026-08-28评分0

Aficamten 用于有症状的非梗阻性肥厚型心肌病

Aficamten for Symptomatic Nonobstructive Hypertrophic Cardiomyopathy

导读

Aficamten 在治疗有症状的非梗阻性肥厚型心肌病患者的临床试验中显示出积极结果。该研究评估了药物对患者运动能力和症状的改善作用。详细数据发表于《新英格兰医学杂志》。

来源:NEJM · nejm.org